[Special Stock] DXVX Hits Upper Limit on News of Accelerated Obesity Treatment Development↑
Biohealthcare specialist company DXVX has hit the upper price limit (the highest daily price limit).
As of 2:42 PM on the 18th, DXVX is trading at 2,195 KRW, up 506 KRW (29.96%) from the previous trading day.
This rise appears to be driven by news accelerating the development of an oral obesity treatment.
Hot Picks Today
"Banks Roll Out 'High-Interest Specials' Offering Up to 7-13% a Year: 'Why Not Choose Savings Over Stocks?'"
- [Exclusive] "Korea Gains Reputation as a 'Pension Hotspot'": NPS Grants Benefits to Foreign Parents and Children Living Abroad
- "Prices Plunged by 40%": After Buying from Korea, Japan Faces Crisis Over Surplus Rice
- "What Do the Ten Characters Mean?" Academia Abuzz Over 3.93 kg Palm-Sized Stone Fragment: "Is It Goguryeo or Silla?"
- “The Road From Apartment to Han River Is Dark and Dangerous”…Banpo ‘This Park’ Gets Approved, Apgujeong, Seongsu, and Yongsan Also Celebrate [The Future of Parks ⑨]
On the same day, DXVX announced that based on previous research results confirming superiority over control substances in late-stage clinical trials, it is currently optimizing its oral GLP (glucagon-like peptide)-1 obesity drug candidate.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.
